Search results

We are excited to announce that Fredrik Radencrantz will join our team as the new Business Development Director. With three decades of experience in the MedTech, BioTech, Pharma, and Life Sciences sectors, Fredrik brings a wealth of expertise and a deep commitment to improving the quality of life for patients worldwide through innovative solutions. Fredrik’s career journey spans a diverse range of roles across both emerging start-ups and well-established companies. His impressive background includes business development positions at globally recognized organizations such as Ericsson, Iconovo, Probi, and Arjo. Fredrik has consistently demonstrated his passion for driving international sales and business growth, all while maintaining a focus on patient-centric innovation. In addition to his professional accomplishments, Fredrik holds a Bachelor’s degree in Liberal Arts with a focus on East and Southeast Asian Studies from Williams College, USA. He has also studied Economics, Corporate Finance, and Marketing at Lund University, providing him with a strong foundation in both the business and global aspects of the Life Sciences industry. With his extensive experience, enthusiasm, and dedication to improving healthcare outcomes, Fredrik will be a valuable addition to our team. Please join us in welcoming Fredrik to our team. We are excited about the future and look forward to the continued success we will achieve together. We are said to inform you that Peter Martinsson has decided to pursue new opportunities outside our Company. We would like to thank Peter for his commitment, dedication and support to our customers and distributors for the past three years. Peter’s resilience and problem-solving mindset, passion, and customer-first approach will be missed. We wish Peter all the best with his future endeavors within the logistic industry. We are confident that he will continue to build new customer relationships and make an impact wherever he goes. All the best Peter!

We will be exhibiting at Biologics World Nordics, a Nordic fair held in Stockholm (Älvsjömässan) on March 5–6. You are welcome to visit us and discuss your processes and needs for monitoring temperature-sensitive pharmaceuticals or other biological products. For more information, see the link below. https://www.imapac.com/events/biologics-world-nordics-2025 Vi kommer ställa ut på Biologics World Nordics, en nordisk mässa som hålls i Stockholm (Älvsjömässan) den 5–6 mars. Varmt välkommen att besöka oss och diskutera hur era processer och behov ser ut för övervakning av temperaturkänsliga läkemedel eller andra biologiska produkter. För mer information, se länk nedan. https://www.imapac.com/events/biologics-world-nordics-2025

Sciamed Ltd and Tridentify participated together on the annual event jointly arranged by UK NEQASBTLP and BTS Blood Bank Technology SIG held in Manchester, 25-26th November 2024. Approx 300 participants with focus on blood transfusion management were there. The interest to discuss cold chain visibility and quality control of temperature, light exposure and impact were high. The QTA Tracer Systems uniqueness of the continuous calculation of the remaining shelf life  in real time of any blood component raised many good dialogues. Opportunity to improved processes with the QTA Tracer System with validated fields according to ISBT-standard were greatly noticed. If you are located in the UK/Ireland, contact Sciamed Ltd for testing the quality solution of Tridentify.

Date: 2024-04-09 Tridentify are delighted to announce that Intrance Medical Systems Inc. now have signed a LOI purchase commitment of $ 300 000. Our Tridentify safeguarding solution will be used for the “logistic journey” of the drug component for clinical trials in at least Europe and the US for patients with Parkinson diseases in advanced stage. The clinical development program for US registration has recently been initiated, with a larger more extensive study planned for late 2024. - Intrance Medical Systems is focused on the development and commercialization of its lead clinical product for the treatment of advanced Parkinson’s disease. The product, Lecigon, is successfully marketed and available across Europe (by Britannia Pharmaceuticals). Intrance Medical plans to bring this innovative system to the US, Canada, Japan, Taiwan and LATAM. The US clinical development program includes key studies where accurate data to the FDA is paramount. Since Lecigon requires an unbroken cold supply chain and whose properties can change if improperly handled, we have found that Tridentify has a unique solution with monitoring and continuous calculation of remaining shelf life. We’re excited about our collaboration and anticipate extending our partnership in the future, says Patrick Shea, CEO at Intrance Medical Systems Inc. - Tridentify is excited about the next steps with Intrance Medical Inc. Together with Intrance we want to ensure high quality standards in their important development of a new Parkinson treatment. We are proud to be able to safeguard the shipments for the clinical trials in Europe and in the US, as well as to support the important safety for patients with severe diseases, says Ann-Christine Jungmar, CEO at Tridentify. About Tridentify AB Tridentify is a Swedish Software-as-a-Service MedTech company that helps customers control the entire supply chain and cold chain logistics for costly sensitive drugs, vaccines, blood, organs and other temperature-sensitive goods. The company has a unique and patented SaaS/IoMT system that monitors in real time the status of the product and continuously calculates its remaining shelf-life and that it safely fulfils its purpose. With the Safeguarding solution, you always have a close eye on how your temperature sensitive products are doing during the journey. Unlike other solutions, Tracer System® is programmed to understand and sense exactly how different types of medicines, vaccines, blood, plasma and organs are affected during a transport, throughout the life cycle of the products. With our medical technology - not just a logistics tool - sensitive goods can be put into use immediately after delivery without a formal QA. A revolution in industry to save time, money and most importantly - ensure security and functionality for the end user!  Our technology makes it safer and easier to comply with current and future legislation and medical requirements. In the end, this means safe products, safe patients and minimal wastage. Tridentify has a SaaS solution using a unique IoT Tracer that is a MDD MedTech Device Class IIa*. *MDD Certificate extended to end of 2028 due to Article 120 of MDR For more information, visit tridentify.com About Intrance Medical Systems Inc Intrance Medical Systems, Inc., is a private, U.S.-based biopharmaceutical company focused on the development and commercialization of its lead clinical product for the treatment of advanced Parkinson’s disease in the U.S., Canada, South America, Japan and Taiwan. Intrance’s lead product, known as Lecigon® in the European market, is a fixed-dose combination treatment of levodopa, carbidopa and entacapone for enteral infusion in advanced Parkinson’s disease patients. The company has received FDA clearance for its IND application and is advancing its clinical development program for this targeted indication. For more information, visit intrancemedical.com For further information, kindly contact: Ann-Christine Jungmar, CEO Tridentify +46 708 71 46 76 ann-christine.jungmar@tridentify.com

Ser framemot att delta på QA Forum och ta del av nyheter inom GMP, GDP, best practices och andra kvalitetsförändringar. Flera intressanta föreläsningar och diskussioner kring erfarenheter, lärdomar, brist på läkemedel, kvalitetssäkring mm. Vår molnbaserade Medtech SaaS/IoMT lösning kan användas i kylkedjelogistiken av t ex kostsamma och känsliga läkemedel, vacciner mm. Vi beräknar kontinuerligt stabilitetsdata - säkra produkter, säkra patienter och minimerad kassation. Vill du veta mer? Hoppas vi ses där ! Ann-Christine Jungmar, CEO

Tridentify delivers an advanced SaaS system connecting to IoT tracers, able to overcome the limitations of the current available logging technologies. Unlike other solutions, Tridentify’s patented QTA tracer is configured down to an organizational level, to the exact specifications of the sensitive goods. This gives it the ability to communicate the remaining shelf life of the individual package in real-time.

Tridentify AB has signed a contract with Intrance Medical Systems regarding the purchase and delivery of the Tridentify Tracer Solution. The Seller (Tridentify AB) has developed an advanced SaaS and IoT system for the real-time monitoring and continuous stability control of pharmaceuticals in the cold chain. The Buyer (Intrance Medical Systems Inc) has developed a drug/device treatment system for patients suffering from Parkinson´s diseases in an advanced stage. The drug component is expected to be delivered internationally and need to be transported under refrigerated conditions. The intended transaction involves the Seller providing the monitoring system as a fee for service, covering safeguarding services of shipments of the pharmaceutical products used in the Buyer´s clinical development program including clinics in the EU and the US. -  Tridentify is delighted about the interest that Intrance Medical Systems has shown in our Tracer Solution. We are proud that Intrance is to become our first signed biomedical customer and that we will be able to support the development of a new Parkinson treatment in the US, says Johan Stormlund, CEO at Tridentify. About Tridentify AB Tridentify is a Swedish Software-as-a-Service MedTech company that helps customers control the entire supply chain and cold chain logistics for transfusion medicine blood, plasma and other temperature-sensitive goods. After further development work, we can now provide our unique system to the entire spectrum of sensitive and expensive biomedicine. Our safeguarding Tracer System accurately measures temperature and condition, throughout the life cycle of biological and pharma products. Unlike all other solutions, the Tracer System® is programmed to the exact specifications of the medicine. This gives it the ability to communicate the shelf life of the actual individual package it is attached to in real time. With Tridentify's SaaS/IoT system, the costs of delivery audits are reduced. There is significantly less wastage and less destroyed biopharma. Our technology makes it safer and easier to comply with current and future legislation and medical requirements. Finally, and most importantly, we increase the safety for the patient who can trust that the Biopharma fulfills its function. For more information, visit tridentify.com About Intrance Medical Systems Inc Intrance Medical Systems, Inc., a subsidiary of Sweden-based Intrance Holdings AB, is a private biopharmaceutical company focused on the development and commercialization of its lead clinical product for the treatment of advanced Parkinson’s disease in the U.S., Canada, South America, Japan and Taiwan. For more information, visit intrancemedical.com

Tridentify's recent participation in the highly anticipated ISB 2023 in Gothenburg was an enormous success! As one of the event's proud sponsors, we had the opportunity to showcase our revolutionary temperature monitoring system and connect with industry professionals from around the world. Representatives from various countries and diverse backgrounds visited our booth, providing us with a global perspective and reinforcing the importance of our temperature monitoring solution on an international scale. We had the privilege of engaging in meaningful discussions, exchanging insights, and exploring potential collaborations with industry leaders, healthcare professionals, and decision-makers. For those who couldn't attend ISB 2023, don't worry! We are committed to keeping you updated on the latest advancements in our temperature monitoring system and its successful implementations. Stay tuned to our social media channels, and website, for informative content, product updates, and testimonials from satisfied customers.

Tridentify looks forward to sponsoring and attending the 33rd ISBT congress in Gothenborg, June 17-21st. Come visit us at our booth #2927, and learn more about how our customers are saving up to 90% of their waste by using our temperature monitoring system.

Tridentify, a leading provider of supply chain monitoring and management solutions, is excited to announce the launch of their latest product – a real-time monitoring system for temperature-sensitive shipments that include GPS geo-tracking and real-time calculation of remaining stability budget. This new monitoring system provides an all-in-one solution for tracking temperature-sensitive shipments, providing users with real-time data on the location and temperature of their products. With GPS geo-tracking, customers can follow their shipments from start to finish, ensuring that they are delivered to the right location at the right time. The real-time calculation of remaining stability budget provides an additional layer of protection, reducing waste and increasing patient safety by ensuring that the products are stored at the correct temperature throughout the entire supply chain. "We are thrilled to launch this new monitoring system, which provides our customers with the ability to track their temperature-sensitive shipments in real-time, including GPS geo-tracking and real-time calculation of remaining stability budget," said Johan Stormlund, CEO of Tridentify. "This is a game-changer for the industry, as it will help our customers to reduce waste, increase patient safety and ultimately save lives."

Come join our roundtable session at Logipharma 2023. The topic is: Taking QA decisions in realtime based on algorithms". Join us as we discuss real time decision-making with Mr Johan Stormlund (Thought leader), CEO, Tridentify, Mr Tomas Fant (Co-leader), Pfizer, Temperature Controlled Logistics Projects Lead and Mr Brett Marshall (Co-leader), Zuellig Pharma, Corporate Head, Quality.Tuesday 25th April, at 15:25, Track C – Mastering Temperature Controlled Operations.Welcome!

Tridentify is a proud sponsor of Logipharma 2023. The event will be held in Lyon, France 25-27th April. I´m looking forward to meeting you all there. And I can promise we will have some exciting news to share during the event.